CLINICAL TRIALS PROFILE FOR AGRYLIN
✉ Email this page to a colleague
All Clinical Trials for AGRYLIN
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00648024 ↗ | Fasting Study of Anagrelide Hydrochloride Capsules 1 mg to Agrylin® Capsules 1 mg | Completed | Mylan Pharmaceuticals | Phase 1 | 2003-01-01 | The objective of this study was to investigate the bioequivalence of Mylan's anagrelide HCl 1 mg capsules to Shire US's Agrylin® 1 mg capsules following a single, oral 1 mg (1 x 1 mg) dose administration under fasting conditions. |
| NCT00648765 ↗ | Fed Study of Anagrelide Hydrochloride Capsules 1 mg to Agrylin® Capsules 1 mg | Completed | Mylan Pharmaceuticals | Phase 1 | 2003-01-01 | The objective of this study was to investigate the bioequivalence of Mylan's anagrelide HCl 1 mg capsules to Shire US's Agrylin® 1 mg capsules following a single, oral 1 mg (1 x 1 mg) dose administration under fed conditions. |
| NCT01467661 ↗ | Long-term Safety of SPD422 in Japanese Adults With Essential Thrombocythaemia | Completed | Shire | Phase 3 | 2010-10-27 | The purpose of this study is to provide SPD422 to subjects who completed Study SPD422 308 and, in the opinion of the Investigator, will continue to benefit from treatment. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for AGRYLIN
Condition Name
Clinical Trial Locations for AGRYLIN
Trials by Country
Clinical Trial Progress for AGRYLIN
Clinical Trial Phase
Clinical Trial Sponsors for AGRYLIN
Sponsor Name
